The nitrosamine contamination of drugs, part 3: Quantification of 4-Methyl-1-nitrosopiperazine in rifampicin capsules by LC-MS/HRMS
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 203, 114205
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Risk assessment report of potential impurities in cetirizine dihydrochlorideJournal of Pharmaceutical and Biomedical Analysis, 2020
- The contamination of valsartan and other sartans, part 1: New findingsJournal of Pharmaceutical and Biomedical Analysis, 2019
- The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impuritiesJournal of Pharmaceutical and Biomedical Analysis, 2019
- Method transfer for fast liquid chromatography in pharmaceutical analysis: Application to short columns packed with small particle. Part II: Gradient experimentsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Kinetics of the aminolysis and hydrolysis of alkyl nitrites: Evidence for an orbital controlled mechanismMonatshefte für Chemie - Chemical Monthly, 1996
- Aerial oxidation of hydrazines to nitrosaminesEnvironmental and Molecular Mutagenesis, 1991
- History of the Development of RifampinClinical Infectious Diseases, 1983
- Synthesis and Oxidation of 2-Amino-2,3-dihydro-1H-benz[de]isoquinoline and 1,2,3,4-Tetrahydronaphtho[1,8-de][1,2]diazepine and Related Cyclic 1,2-DibenzylhydrazinesJournal of the American Chemical Society, 1963